Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 16:45:41 GMT 2025
by
admin
on
Wed Apr 02 16:45:41 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1|LAMDA |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
DNV66ACK7K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000051276
Created by
admin on Wed Apr 02 16:45:41 GMT 2025 , Edited by admin on Wed Apr 02 16:45:41 GMT 2025
|
PRIMARY | |||
|
12887
Created by
admin on Wed Apr 02 16:45:41 GMT 2025 , Edited by admin on Wed Apr 02 16:45:41 GMT 2025
|
PRIMARY | |||
|
DNV66ACK7K
Created by
admin on Wed Apr 02 16:45:41 GMT 2025 , Edited by admin on Wed Apr 02 16:45:41 GMT 2025
|
PRIMARY | |||
|
2839417-54-6
Created by
admin on Wed Apr 02 16:45:41 GMT 2025 , Edited by admin on Wed Apr 02 16:45:41 GMT 2025
|
PRIMARY | |||
|
C192110
Created by
admin on Wed Apr 02 16:45:41 GMT 2025 , Edited by admin on Wed Apr 02 16:45:41 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 2_22 | 2_96 |
| 2_149 | 2_205 |
| 2_225 | 4_216 |
| 2_266 | 2_326 |
| 1_149 | 1_205 |
| 2_372 | 2_430 |
| 3_22 | 3_90 |
| 3_139 | 3_198 |
| 4_22 | 4_90 |
| 4_139 | 4_198 |
| 1_225 | 3_216 |
| 1_231 | 2_231 |
| 1_234 | 2_234 |
| 1_266 | 1_326 |
| 1_372 | 1_430 |
| Glycosylation Type | MAMMALIAN, AFUCOSYLATED |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_302 |
| N | 2_302 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
BAY 3375968 is a monoclonal antibody (mAb) designed to deplete the C-C motif chemokine receptor 8 (CCR8)-positive regulatory T cells (Tregs) via antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP)
|
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [3_1] [4_1] | N-TERMINUS | PIDOLIC ACID | SZB83O1W42 | ||
| AMINO ACID REMOVAL | [1_452] [2_452] | C-TERMINUS | LYSINE | K3Z4F929H6 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|